MORC2 and breast cancer: Yang et al. discovered that the phosphorylation of MORC2 in response to estrogen and antiestrogens inhibits CMA-mediated lysosomal degradation and plays a significant role in estrogen-induced proliferation and resistance to antiestrogen therapies in breast cancer [55].